Effect of Clostridium butyricum and its components in different concentrations on epithelial-mesenchymal transition of ulcerative colitis

被引:1
|
作者
Shen, Yuan-Yuan [1 ,2 ]
Liu, Cheng-Xia [2 ]
Chen, Fei-Xue [1 ]
Zhang, Qian [3 ]
Zhang, Ying-Zhe [4 ]
Zhang, Ran-Ran [2 ]
Li, Yan-Qing [1 ]
机构
[1] Shandong Univ, Qilu Hosp, Dept Gastroenterol, 107 Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China
[2] Binzhou Med Univ Hosp, Dept Digest Med, Binzhou, Shandong, Peoples R China
[3] Binzhou Med Univ Hosp, Dept Pathol, Binzhou, Shandong, Peoples R China
[4] Binzhou Med Univ Hosp, Dept Thyroid & Breast Surg, Binzhou, Shandong, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2018年 / 11卷 / 09期
关键词
Clostridium butyricum; ulcerative colitis; EMT; dose-dependent; NF-KAPPA-B; INFLAMMATORY BOWEL DISEASES; SULFATE-INDUCED COLITIS; CHAIN FATTY-ACIDS; BUTYRATE; MICE; CELLS; DSS; PROLIFERATION; ACTIVATION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To investigate the effect and potential mechanism of Clostridium butyricum (CB) in different concentrations on epithelial-mesenchymal transition (EMT) of ulcerative colitis. Methods: Fifty C57BL/6 mice were randomly divided as a control group, a DSS group, a low-dose, a middle-dose and a high-dose CB treated group. DAI, colon length, and tissue damage for each group was assessed. Expression of E-cadherin and Vimentin in the colon was detected by real-time qPCR and IHC. In vitro, the control, TGF-beta 1, low-dose, high-dose supernatant and dead CB groups were monitored for loss of cell polarity and expression of phenotype by real time qPCR and Western blotting. Results: Compared to the control group, DAI and colon length in the DSS group was significantly deteriorated (P<0.05) with most crypt loss and infiltrating inflammatory cells as significantly down-regulation of E-cadherin and up-regulation of Vimentin by IHC staining (P<0.05). Not like the high-dose CB group, DAI, colon length and tissue damage in the low-dose and middle-dose CB group was critically ameliorated on the final experimental day (P<0.05) with up-regulation E-cadherin and down-regulation vimentin. In vitro, supernatant and the dead CB group, especial the high-dose dead CB, could prevent loss of cell polarity. Dead and high-dose supernatant of CB could significantly down-regulate vimentin mRNA (P<0.05), when supernatant of both CB groups could up-regulate expression of E-cadherin mRNA by regulating TGF-beta 1 mRNA. At the protein level, high-dose supernatant of CB could increase expression of E-cadherin and decrease that of vimentin. Conclusion: Clostridium butyricum could dose-dependently suppress experimental colitis because of its components inhibiting EMT undergoing down-regulation TGF-beta 1.
引用
收藏
页码:9028 / 9037
页数:10
相关论文
共 50 条
  • [31] Differential expression of moesin in breast cancers and its implication in epithelial-mesenchymal transition
    Wang, Chung-Chieh
    Liau, Jau-Yu
    Lu, Yen-Shen
    Chen, Jun-Wei
    Yao, Yu-Tung
    Lien, Huang-Chun
    HISTOPATHOLOGY, 2012, 61 (01) : 78 - 87
  • [32] Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy
    Hong-Tao Chen
    Hao Liu
    Min-Jie Mao
    Yuan Tan
    Xiang-Qiong Mo
    Xiao-Jun Meng
    Meng-Ting Cao
    Chu-Yu Zhong
    Yan Liu
    Hong Shan
    Guan-Min Jiang
    Molecular Cancer, 18
  • [33] Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy
    Chen, Hong-Tao
    Liu, Hao
    Mao, Min-Jie
    Tan, Yuan
    Mo, Xiang-Qiong
    Meng, Xiao-Jun
    Cao, Meng-Ting
    Zhong, Chu-Yu
    Liu, Yan
    Shan, Hong
    Jiang, Guan-Min
    MOLECULAR CANCER, 2019, 18 (1)
  • [34] Effect of Baricitinib on the epithelial-mesenchymal transition of alveolar epithelial cells induced by IL-6
    Liu, Yiping
    Hu, Ming
    Fan, Guanzhi
    Xing, Nanshu
    Zhang, Rong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 110
  • [35] Regulatory Proteins of Epithelial-Mesenchymal Transition and Some Components of VEGF Signaling Pathway in Breast Cancer
    Scherbakov, A. M.
    Gershtein, E. S.
    Korotkova, E. A.
    Ovchinnikova, L. K.
    Ovsii, O. G.
    Ermilova, V. D.
    Gens, G. P.
    Kushlinskii, N. E.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 160 (06) : 802 - 806
  • [36] Effect and Mechanism of TL1A Expression on Epithelial-Mesenchymal Transition during Chronic Colitis-Related Intestinal Fibrosis
    Jia Wenxiu
    Yang Mingyue
    Han Fei
    Luo Yuxin
    Wu Mengyao
    Li Chenyang
    Song Jia
    Zhang Hong
    Shih, David Q.
    Targan, Stephan R.
    Zhang Xiaolan
    MEDIATORS OF INFLAMMATION, 2021, 2021
  • [37] Extracellular matrix components direct chromatin texture and nuclear morphological changes in epithelial-mesenchymal transition
    Verdone, James E.
    Veltri, Robert W.
    Mooney, Steven M.
    Hernandez, James R.
    Harberg, Calvin A.
    Coffey, Donald S.
    Pienta, Kenneth J.
    CANCER RESEARCH, 2014, 74 (19)
  • [38] Effect of Trichostatin A on radiation induced epithelial-mesenchymal transition in A549 cells
    Nagaraja, SunilGowda Sunnaghatta
    Krishnamoorthy, Vishnuvarthan
    Raviraj, Raghavi
    Paramasivam, Alagudinesh
    Nagarajan, Devipriya
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (04) : 1534 - 1541
  • [39] Regulatory Proteins of Epithelial-Mesenchymal Transition and Some Components of VEGF Signaling Pathway in Breast Cancer
    A. M. Scherbakov
    E. S. Gershtein
    E. A. Korotkova
    L. K. Ovchinnikova
    O. G. Ovsii
    V. D. Ermilova
    G. P. Gens
    N. E. Kushlinskii
    Bulletin of Experimental Biology and Medicine, 2016, 160 : 802 - 806
  • [40] The Effect of Resveratrol and Quercetin on Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem Cell
    Hoca, Mustafa
    Becer, Eda
    Kabadayi, Hilal
    Yucecan, Sevinc
    Vatansever, Hafize Seda
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2020, 72 (07): : 1231 - 1242